Cargando…

Stability of extemporaneously compounded amiloride nasal spray

Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride...

Descripción completa

Detalles Bibliográficos
Autores principales: Yellepeddi, Venkata, Sayre, Casey, Burrows, Anna, Watt, Kevin, Davies, Simon, Strauss, John, Battaglia, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351165/
https://www.ncbi.nlm.nih.gov/pubmed/32649677
http://dx.doi.org/10.1371/journal.pone.0232435
_version_ 1783557397396062208
author Yellepeddi, Venkata
Sayre, Casey
Burrows, Anna
Watt, Kevin
Davies, Simon
Strauss, John
Battaglia, Marco
author_facet Yellepeddi, Venkata
Sayre, Casey
Burrows, Anna
Watt, Kevin
Davies, Simon
Strauss, John
Battaglia, Marco
author_sort Yellepeddi, Venkata
collection PubMed
description Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct “nose-to-brain” access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicating HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature.
format Online
Article
Text
id pubmed-7351165
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-73511652020-07-20 Stability of extemporaneously compounded amiloride nasal spray Yellepeddi, Venkata Sayre, Casey Burrows, Anna Watt, Kevin Davies, Simon Strauss, John Battaglia, Marco PLoS One Research Article Anxiety disorders (AD) are the most common mental conditions affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in reducing anxious responses in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct “nose-to-brain” access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicating HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature. Public Library of Science 2020-07-10 /pmc/articles/PMC7351165/ /pubmed/32649677 http://dx.doi.org/10.1371/journal.pone.0232435 Text en © 2020 Yellepeddi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yellepeddi, Venkata
Sayre, Casey
Burrows, Anna
Watt, Kevin
Davies, Simon
Strauss, John
Battaglia, Marco
Stability of extemporaneously compounded amiloride nasal spray
title Stability of extemporaneously compounded amiloride nasal spray
title_full Stability of extemporaneously compounded amiloride nasal spray
title_fullStr Stability of extemporaneously compounded amiloride nasal spray
title_full_unstemmed Stability of extemporaneously compounded amiloride nasal spray
title_short Stability of extemporaneously compounded amiloride nasal spray
title_sort stability of extemporaneously compounded amiloride nasal spray
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351165/
https://www.ncbi.nlm.nih.gov/pubmed/32649677
http://dx.doi.org/10.1371/journal.pone.0232435
work_keys_str_mv AT yellepeddivenkata stabilityofextemporaneouslycompoundedamiloridenasalspray
AT sayrecasey stabilityofextemporaneouslycompoundedamiloridenasalspray
AT burrowsanna stabilityofextemporaneouslycompoundedamiloridenasalspray
AT wattkevin stabilityofextemporaneouslycompoundedamiloridenasalspray
AT daviessimon stabilityofextemporaneouslycompoundedamiloridenasalspray
AT straussjohn stabilityofextemporaneouslycompoundedamiloridenasalspray
AT battagliamarco stabilityofextemporaneouslycompoundedamiloridenasalspray